The earnings call reflected a positive outlook for Monogram Technologies, with significant achievements such as FDA clearance and regulatory approval in India marking major milestones. The company has shown improvement in financial metrics with a reduced cash burn rate. However, the need for additional capital and a slow initial rollout were noted as challenges. Overall, the positive highlights significantly outweigh the lowlights, painting an optimistic picture for the company's future.

Company Guidance -

Q3 2025

During Monogram Technologies' Q1 2025 call, the company emphasized its robust financial position, with $13.3 million in cash and a reduced monthly cash burn rate of $0.8 million compared to the previous year's $1.1 to $1.2 million. This financial prudence is expected to sustain operations through upcoming milestones, with an anticipated $1 million monthly burn rate and $1.2 million allocated for a six to nine-month clinical trial. Notably, the company achieved FDA 510(k) clearance for its mBôs TKA system, a landmark for autonomous robotic knee surgeries, and secured regulatory approval for a clinical trial in India. Monogram is strategically positioning itself against entrenched competitors like Stryker by focusing on system accuracy, safety, and efficiency. With plans for a slow rollout and capital needs aligned with growth acceleration, Monogram aims to leverage its technology to capture market share in the evolving orthopedic robotics landscape.

FDA Clearance Achieved

Monogram Technologies received 510(k) clearance from the FDA for the mBôs TKA system. This is a major milestone for the company, representing years of effort and innovation.

Regulatory Approval in India

The company received regulatory approval from the CDSCO to initiate a multicenter clinical trial in India in collaboration with Shalby Hospitals. This marks the first clinical investigation involving autonomous saw-based robotic total knee surgeries.

Improved Cash Burn Rate

The monthly cash burn decreased from $1.1 million to $1.2 million last year to about $0.8 million this quarter, reflecting cost optimization efforts.

Strong Financial Position

Monogram has $13.3 million in cash with no traditional debt, positioning the company well for future milestones.

Propelling Forward with Pilot Placements

The company is set to begin pilot placements in the U.S., which will involve approximately four surgeons to demonstrate the clinical performance of their system.

Monogram Orthopaedics Inc (MGRM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MGRM Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 13, 2025	2025 (Q3)	- / -	-0.16	―	―	―
Aug 13, 2025	2025 (Q2)	-0.13 / -0.16	-0.11	-44.55% (-0.05)	―	―
May 14, 2025	2025 (Q1)	-0.12 / -0.10	-0.11	9.09% (<+0.01)	―
Mar 12, 2025	2024 (Q4)	-0.11 / -0.08	0.09	-188.89% (-0.17)
Nov 14, 2024	2024 (Q3)	-0.12 / -0.16	-0.034	-370.59% (-0.13)	―	―
Aug 14, 2024	2024 (Q2)	-0.09 / -0.11	-0.272	59.56% (+0.16)	―	―
May 14, 2024	2024 (Q1)	-0.12 / -0.11	-0.132	16.67% (+0.02)	―
Mar 15, 2024	2023 (Q4)	- / 0.09	-0.25	136.00% (+0.34)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MGRM Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 13, 2025	$5.37	$5.35	-0.37%
May 14, 2025	$2.50	$2.72	+8.80%
Mar 12, 2025	$2.32	$2.31	-0.43%
Nov 14, 2024	$2.01	$2.05	+1.99%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Monogram Orthopaedics Inc (MGRM) report earnings?

Monogram Orthopaedics Inc (MGRM) is schdueled to report earning on Nov 13, 2025, Before Open (Confirmed).

What is Monogram Orthopaedics Inc (MGRM) earnings time?

Monogram Orthopaedics Inc (MGRM) earnings time is at Nov 13, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MGRM EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing